To test if in vitro evidence were also reflected in the outcome of chemotherapy-treated patients, we retrospectively analysed a small case-series of NSCLC patients treated with pemetrexed-based chemotherapy and found that higher TS gene expression significantly associated with worse prognosis (Fig. 1g). Here, TYMS is linked to non-small cell lung carcinoma.